VIROPHARMA INC 4
4 · VIROPHARMA INC · Filed Jan 28, 2014
Insider Transaction Report
Form 4
VIROPHARMA INCVPHM
Leone John R
Director
Transactions
- Disposition from Tender
Common Stock
2014-01-24$50.00/sh−11,000$550,000→ 0 total - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−15,000→ 0 totalExercise: $5.68From: 2010-02-22Exp: 2019-02-22→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-01-24−15,000→ 0 totalExercise: $25.25From: 2014-02-22Exp: 2023-02-22→ Common Stock (15,000 underlying) - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−10,000→ 0 totalExercise: $20.15From: 2007-02-20Exp: 2016-02-19→ Common Stock (10,000 underlying) - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−25,000→ 0 totalExercise: $20.43From: 2007-01-19Exp: 2016-01-19→ Common Stock (25,000 underlying) - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−10,000→ 0 totalExercise: $17.76From: 2008-02-26Exp: 2017-02-25→ Common Stock (10,000 underlying) - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−10,000→ 0 totalExercise: $9.15From: 2009-02-25Exp: 2018-02-25→ Common Stock (10,000 underlying) - Disposition to Issuer
Non-qualified Stock Option (Right to Buy)
2014-01-24−15,000→ 0 totalExercise: $31.74From: 2013-02-24Exp: 2022-02-24→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-01-24−15,000→ 0 totalExercise: $10.76From: 2011-02-22Exp: 2020-02-22→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-01-24−15,000→ 0 totalExercise: $17.30From: 2012-02-21Exp: 2021-02-21→ Common Stock (15,000 underlying) - Disposition to Issuer
Restricted Stock Units
2014-01-24−4,500→ 0 total→ Common Stock (4,500 underlying)
Footnotes (5)
- [F1]The options vest in three equal annual installments beginning on the first anniversary date from time of grant.
- [F2]This derivative security, regardless of whether otherwise previously vested, was canceled in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 in exchange for a cash payment representing, in the case of stock options, the difference between the per-share exercise price of the stock option and $50, and in the case of restricted stock units, $50 per share.
- [F3]The options vest in full one year from date of grant
- [F4]Each restricted stock unit represents a contingent right to receive one share of VPHM common stock.
- [F5]The restricted stock unit vests in full one year from the date of grant. Vested shares will be delivered to the reporting person upon vesting.